Nov 12, 2024, 13:38
Shabnam Eghbali on Metastatic Melanoma treated with IO therapy – Vanderbilt Hem/Onc
Vanderbilt Hem/Onc shared a post on X:
“Dr. Shabnam Eghbali, PGY-2, Vanderbilt University Medical Center presented her work in metastatic Melanoma Society for Immunotherapy of Cancer SITC2024 treated with IO therapy:
- LILRB RNA expression = (+) prognostic biomarker.
- LILRB3 and LILRB4 leads to PFS/OS.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 20:23
Dec 2, 2024, 19:24
Dec 2, 2024, 19:20
Dec 2, 2024, 19:16
Dec 2, 2024, 19:06
Dec 2, 2024, 19:02